TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pharmaq AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
1,095,886
|
912,925
|
831,927 |
Financial expenses |
56,528
|
58
|
1,032 |
Earnings before taxes |
545,837
|
405,624
|
432,965 |
Total assets |
2,002,742
|
1,602,737
|
1,237,413 |
Current assets |
1,703,239
|
1,230,209
|
917,634 |
Current liabilities |
275,916
|
206,373
|
204,841 |
Equity capital |
1,726,202
|
1,389,080
|
1,021,533 |
- share capital |
12,128
|
12,800
|
12,145 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
86.2%
|
86.7%
|
82.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
49.8%
|
44.4%
|
52.0% |
Return on assets (ROA) |
30.1%
|
25.3%
|
35.1% |
Current ratio |
617.3%
|
596.1%
|
448.0% |
Return on equity (ROE) |
31.6%
|
29.2%
|
42.4% |
Change turnover |
230,913
|
36,170
|
51,115 |
Change turnover % |
27%
|
4%
|
7% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.